Skip to content
Home
Technology
Company
News
In the News
Press Releases
Contact
Menu
Home
Technology
Company
News
In the News
Press Releases
Contact
Micron Biomedical
News & Press Releases
In The News
Reuters Spotlights Micron’s Progress Toward Mass Production of Its Proprietary Microarray Technology
November 16, 2023
Read More
FiercePharma Spotlights Micron Biomedical’s Progress to Commercializing a Life-Saving “Button”
November 16, 2023
Read More
Atlanta News First Spotlights Micron Biomedical’s “Game Changing Technology”
November 16, 2023
Read More
Micron Biomedical CEO to Speak at Reuters Signature Event in a Health Equity Fireside Chat
November 14, 2023
Read More
Impact and Cost-Effectiveness of Microarray Technology Featured in BMJ Journal
November 8, 2023
Read More
Micron Joins Global Life Science Industry Leaders at BioEurope
November 6, 2023
Read More
View All
Press Releases
Micron Biomedical Receives $23.6 Million to Accelerate Commercial Manufacturing of Needle-Free Vaccines and to Help Eradicate Measles
November 16, 2023
Read More
Micron Biomedical Appoints Brian Bernick, MD as Chairman of Its Board of Directors
August 9, 2023
Read More
Micron Biomedical Announces Positive Measles and Rubella Vaccination Results from First Clinical Trial of Microarray Injection-Free Vaccine Delivery in Children
May 17, 2023
Read More
Micron Biomedical Extends Series A to $17 Million to Bring Needle-Free Drugs and Vaccines to Market
May 10, 2023
Read More
Micron Biomedical Secures Series A Financing to Commercialize MAP Technology for Self-Administration of Drugs and Vaccines without Needles
November 28, 2022
Read More
Micron Biomedical Presents at the White House Summit on the Future of COVID-19 Vaccines
July 26, 2022
Read More
View All